Skip to the main content.

Data Solutions
In Silico Discovery
Technology
Insight Hub
- Overview
- Blog
- eBook
- Webinars
- Discover NLP
Company
- Overview
- Careers
- News
- Events
- Contact us
Blog

Search

Search

Data Solutions
In Silico Discovery
Technology
Insight Hub
- Overview
- Blog
- eBook
- Webinars
- Discover NLP
Company
- Overview
- Careers
- News
- Events
- Contact us
Blog

Powering
Biotherapeutic
Intelligence™

Insight Hub

Overview
Blog
eBooks
Webinars
Discover NLP

See our latest blog to Blog Listing

to Blog Listing

Contact us to Contact Page

to Contact Page

Powering
Biotherapeutic
Intelligence™

Company

Overview
Careers
Contact

News & Events

In the News
Conferences & Events

See our latest blog to Blog Listing

to Blog Listing

Contact us to Contact Page

to Contact Page

Powering biotherapeutic intelligence

Stories from the leading edge

Blogs

All topics

All
Omics analysis
AI
ML
Precision medicine
Bioinformatics
Drug discovery
NLP
BioStrand Company
R&D
Company culture
Employee spotlight
In silico
Life sciences data management
Antibody discovery
Microbiome
Protein structure prediction
Big data
Biomarker
Cloud computing
Biobank
Biomarkers
Metadata

Insights into genetics and genomics research, and their leading role in the rapid development of the field.

Featured

Computational biology and drug discovery: what to expect in 2023

Computational biology and drug discovery: what to expect in 2023

The year 2022 in computational biology was largely marked by two main advancements:

Most recent

alt=

Creating a unified data + information architecture for scalable AI

alt=

The Importance of Reproducibility in In-Silico Drug Discovery

alt=

Making Sense of Multi-Omics Data

alt=

Creating an AI-ready data foundation for successful AI-enabled drug discovery

alt=

A Hybrid Approach to NLP in Drug Discovery

alt=

Efficient data integration is the key to effective AI/ML

alt=

Accelerating R&D and innovation in life sciences

alt=

Challenges In Multi-Omics Data Integration

See More

Popular

Explained: how to plot the prediction quality metrics with AlphaFold2 icon blue arrow

Explained: A brief look into AlphaFold 2 icon blue arrow

AI, ML, DL, and NLP: An Overview icon blue arrow

Artificial Intelligence in early phase drug development icon blue arrow

Knowledge Graphs & The Power Of Context icon blue arrow

Creating an AI-ready data foundation for successful AI-enabled drug discovery icon blue arrow

Back to Insight Hub

Let’s accelerate change. Partner with us.

Subscribe to our blog:

Technology
- Overview
In Silico Discovery
- Overview
Data Management
- Overview

Insight Hub
- Overview
- Blog
- eBooks
- Webinars
- Discover NLP

Company
- Overview
- News
- Events
- Careers

Connect
- Contact us
- IPA corporate site

Follow Us
Twitter
LinkedIn
YouTube
Medium

Sign-up for latest news, blogs and more

BioStrand is an independently operating subsidiary of IPA

Privacy
Legal Notice
Cookie Policy

© 2023 BioStrand BV. All rights reserved. BioStrand BV is an independently operating subsidiary of ImmunoPrecise Antibodies Ltd. BioStrand is a trademark of BioStrand BV.